Brief: Vera Therapeutics Q3 EPS USD -0.45
09/11/2023 13:00
Nov 09 (Reuters) - Vera Therapeutics Q3 net income USD -20.104 million. * Q3 operating expenses USD 21.756 million * Q3 operating income USD -21.756 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial